Angelo, A. L. D., Cavalcante, L. N., Abe-Sandes, K., Machado, T. B., Lemaire, D. C., Malta, F., . . . Lyra, A. C. (2013). Myxovirus resistance, osteopontin and suppressor of cytokine signaling 3 polymorphisms predict hepatitis C virus therapy response in an admixed patient population: Comparison with IL28B. Elsevier España.
Cytowanie według stylu Chicago (wyd. 17)Angelo, Ana Luiza Dias, Lourianne Nascimento Cavalcante, Kiyoko Abe-Sandes, Taisa Bonfim Machado, Denise Carneiro Lemaire, Fernanda Malta, Joao Renato Pinho, Luiz Guilherme Costa Lyra, i Andre Castro Lyra. Myxovirus Resistance, Osteopontin and Suppressor of Cytokine Signaling 3 Polymorphisms Predict Hepatitis C Virus Therapy Response in an Admixed Patient Population: Comparison with IL28B. Elsevier España, 2013.
Cytowanie według stylu MLA (wyd. 9)Angelo, Ana Luiza Dias, et al. Myxovirus Resistance, Osteopontin and Suppressor of Cytokine Signaling 3 Polymorphisms Predict Hepatitis C Virus Therapy Response in an Admixed Patient Population: Comparison with IL28B. Elsevier España, 2013.